Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

BGM0504

A Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without Diabetes

BrightGene Bio-Medical Technology Co · Phase 2 · Recruiting · Enrollment 200

NCT07658560

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
The dose1 groupn/rn/rn/rn/r
The dose2 groupn/rn/rn/rn/r
The dose3 groupn/rn/rn/rn/r
The dose4 groupn/rn/rn/rn/r
Placebo groupn/rn/rn/rn/r

Not shown

  • The dose1 group: endpoint not reported
  • The dose2 group: endpoint not reported
  • The dose3 group: endpoint not reported
  • The dose4 group: endpoint not reported
  • Placebo group: endpoint not reported